RecruitingNot Applicable

Evaluation of Dynavisc in Pain Reduction Following Revision Surgery for Persistent or Recurrent Carpal Tunnel Syndrome

Belgium, Brazil, Italy50 participantsStarted 2026-03-26

Plain-language summary

The trial will evaluate the efficacy of DYNAVISC in subjects with a diagnosis of persistent or recurrent carpal tunnel syndrome. This is a prospective, multicenter, randomized, evaluator-blinded clinical trial. Results will be stratified based on the method used for median nerve coverage: Group 1 (standard of care surgery followed by DYNAVISC surrounding the median nerve, n=25 participants), Group 2 (standard of care surgery followed by coverage of the median nerve with a hypothenar fat pad flap, n=25

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Physical examination demonstrates positive Phalen test;
✓. Physical examination demonstrates positive Tinel's test;
✓. Physical examination demonstrates positive monofilament test;

What they're measuring

Pain using VAS

Timeframe: 12 weeks

Trial details

NCT IDNCT06593977

SponsorFzioMed

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-08

Contact for this trial

Gere diZerega, MD

805-630-2800 gdizerega@fziomed.com

View on ClinicalTrials.gov More Carpal Tunnel Syndrome (CTS) trials